Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to $390.1 million.

  • Orthofix Medical's Total Liabilities rose 1408.87% to $390.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $390.1 million, marking a year-over-year increase of 1408.87%. This contributed to the annual value of $390.2 million for FY2024, which is 1946.97% up from last year.
  • Per Orthofix Medical's latest filing, its Total Liabilities stood at $390.1 million for Q3 2025, which was up 1408.87% from $378.8 million recorded in Q2 2025.
  • Orthofix Medical's Total Liabilities' 5-year high stood at $390.2 million during Q4 2024, with a 5-year trough of $116.1 million in Q3 2022.
  • Moreover, its 5-year median value for Total Liabilities was $261.3 million (2023), whereas its average is $248.8 million.
  • In the last 5 years, Orthofix Medical's Total Liabilities crashed by 4425.77% in 2021 and then surged by 16820.04% in 2023.
  • Orthofix Medical's Total Liabilities (Quarter) stood at $139.7 million in 2021, then decreased by 12.83% to $121.8 million in 2022, then soared by 168.2% to $326.6 million in 2023, then rose by 19.47% to $390.2 million in 2024, then dropped by 0.01% to $390.1 million in 2025.
  • Its last three reported values are $390.1 million in Q3 2025, $378.8 million for Q2 2025, and $364.8 million during Q1 2025.